Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Verona Pharma Plc ADR (NQ: VRNA )

12.10 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 98
Open 12.10
Bid (Size) 12.20 (1)
Ask (Size) 12.50 (2)
Prev. Close 12.10
Today's Range 12.10 - 12.10
52wk Range 11.39 - 23.07
Shares Outstanding 480,291,822
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
VRNA Stock Earnings: Verona Pharma Misses EPS for Q1 2024
VRNA stock results show that Verona Pharma missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
3 Healthcare Stocks That Have Outperformed Nvidia Since 2022
The healthcare sector is no slouch when it comes to top-performing growth stocks. 
Via The Motley Fool

Performance

YTD
-35.67%
-35.67%
1 Month
-19.06%
-19.06%
3 Month
-28.66%
-28.66%
6 Month
-10.30%
-10.30%
1 Year
-42.71%
-42.71%

More News

Read More
Earnings Scheduled For February 29, 2024
Via Benzinga
Earnings Preview For Verona Pharma
Via Benzinga
3 Stocks That Could Be Monster Winners in 2024
Via The Motley Fool
Verona Pharma's Promising COPD Treatment Puts It in GSK's Acquisition Crosshairs, Analysts Predict Big Moves
Via Benzinga
Expert Ratings for Verona Pharma
Via Benzinga
Earnings Scheduled For August 3, 2023
Via Benzinga
4 Analysts Have This to Say About Verona Pharma
Via Benzinga
Earnings Preview For Verona Pharma
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
Via Benzinga
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Week In Review: Suzhou Duality Out-Licenses Two ADCs To BioNTech In $1.7 Billion Deal
Via Talk Markets
Charles Schwab To Rally Over 19%? Here Are 10 Other Analyst Forecasts For Monday
Via Benzinga
Earnings Scheduled For November 2, 2023
Via Benzinga
Earnings Scheduled For May 9, 2023
Via Benzinga
7 Biotech Stocks That Could Be the Next Big Thing
Via InvestorPlace
PDS Biotechnology, Pulmonx, Tesla And Some Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Why These 7 Healthcare Stocks Could Soar in 2023
Via InvestorPlace
20 Favorite Biotech & Medical Stocks For 2023
Via Talk Markets
Stock Market Falls Sharply Again As Tesla Dives, Micron Hits Chips; Nike, FedEx Strong: Weekly Review
Via Investor's Business Daily
7 Drug Stocks That Will Soar in 2023
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Tesla, Amazon, Nike, FedEx, Verona Pharma: Why These 5 Stocks Are Drawing Investors' Attention Today
Via Benzinga
Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.